Nasdaq
$19.69▲ 0.13%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $930.1MShares out 47.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
14- 5d agoAfter-hours26.10.20 05:10DEFA14AOther#●●●#●●●
Silence Therapeutics plcBullish
Silence Therapeutics has entered into a definitive agreement to be acquired by Merck KGaA in an all-cash transaction. Shareholders will receive $20.00 in cash per ADS, representing a 130% premium over the closing price on October 16, 2026. The transaction is expected to close in the first quarter of 2027.…more
$19.69+0.13%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 5d agoPre-market26.10.19 21:13DEFA14AOther
Silence Therapeutics plc
Silence Therapeutics has entered into a definitive agreement to be acquired by Merck KGaA. Shareholders will receive $20.00 in cash for each ADS held, with the transaction subject to shareholder approval and regulatory clearances.…more
$19.69+0.13%vs prev closeView filingShare - 5d agoPre-market26.10.19 21:058-KKey event
Silence Therapeutics plc
Silence Therapeutics has entered into a definitive agreement to be acquired by Merck KGaA in an all-cash transaction valued at approximately $1.3 billion. Shareholders will receive $20.00 in cash per ADS, representing a 130% premium over the closing price on October 16, 2026. The transaction is expected to close in the first quarter of 2027, subject to shareholder and court approvals.…more
$19.69+0.13%vs prev closeView filingShare
13 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 5d agoPre-market26.10.20 17:32#●●●#●●●
Nasdaq Rises Over 1% as Tech Stocks Lead Market Recovery
The Nasdaq Composite gained over 1% as tech stocks led a market rebound, showing a slight improvement in investor sentiment. Despite the gains, the CNN Fear and Greed index remains in the Extreme Fear zone.…more
$19.69+0.13%vs prev closeShareBenzinga
- 5d agoRegular26.10.20 02:00
●●●●●●●● ●●●●● ●●●●●●
Merck KGaA has agreed to acquire Silence Therapeutics for $1.3 billion in cash to expand its rare disease treatment portfolio. The deal offers a significant premium to shareholders, causing Silence Therapeutics stock to surge.…more
$19.69+0.13%vs prev closeShareBenzinga - 5d agoPre-market26.10.19 21:15
●●●●●●●● ●●●●● ●●●●●●
Trading for a specific stock was temporarily halted and has since resumed. Investors should check official filings for the reason behind the halt and the timing of the resumption.…more
$19.69+0.13%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report